Oncology & Cancer
Leveraging the power of iPS cell technology to study myeloid neoplasm
Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rearrangement between the MECOM and MYC genes, a team of researchers led by Associate Professor Yoshinori Yoshida and Clinical ...
Sep 9, 2024
0
0